Pricing Log in Create free account

AbCellera Biologics Inc. (ABCL) vs Disc Medicine, Inc. (IRON)

AbCellera Biologics Inc. and Disc Medicine, Inc. are both Biotechnology companies. AbCellera Biologics Inc. and Disc Medicine, Inc. are of similar size ($3.6B and $3.5B). Disc Medicine, Inc. has the higher net margin (0.00% vs −248.8%) and the higher return on invested capital (0.00% vs −42.5%). Across the 14 metrics below, AbCellera Biologics Inc. leads on 9 and Disc Medicine, Inc. on 5.

Valuation

Metric ABCL IRON Biotechnology median
P/E n/m n/m 10.60
P/S 54.90 n/m 9.40
P/B 4.05 4.72 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 46.41 n/m 9.02
Earnings yield (4.54%) (8.38%) (32.88%)
Free cash flow yield (3.38%) (6.53%) (23.13%)

Profitability

Metric ABCL IRON Biotechnology median
Gross margin 100.00% 0.00% 68.51%
Operating margin (340.25%) 0.00% 0.00%
Net margin (248.82%) 0.00% 0.00%
Free cash flow margin (180.84%) 0.00% 0.00%
Return on equity (17.30%) (39.08%) (51.96%)
Return on assets (12.15%) (35.12%) (46.06%)
Return on invested capital (42.52%) 0.00% 0.00%

Growth

Metric ABCL IRON Biotechnology median
Revenue growth (TTM) 101.29% — 6.76%
EPS growth (last fiscal year) 10.91% (51.77%) 29.88%
Revenue growth, 5-year CAGR (20.27%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABCL IRON Biotechnology median
Debt to equity 0.00 0.09 0.00
Current ratio 12.77 24.14 4.97
Net debt to EBITDA 2.97 3.12 1.01

Dividend

Metric ABCL IRON Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ABCL IRON Biotechnology median
Market cap 3.61b 3.48b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack